Paracetamol and metabolite pharmacokinetics in infants
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background Data concerning metabolism of paracetamol in infants are scant. Previous studies have examined urinary metabolite recovery rates after a single dose of paracetamol in either neonates ( Methods Infants ( n=47) undergoing major craniofacial surgery were given paracetamol 19-45 mg/kg 6-, 8-, or 12-hourly as either elixir or suppository formulation for postoperative analgesia, after a loading dose of 33-59 mg/kg rectally during the operation. Serum was assayed for paracetamol concentration in 40 of these infants at 5, 8, 11, 14, 17 and 20 h postoperatively. Urine samples were collected every 3 h for 24 h in 15 of these infants. The clearances of paracetamol to glucuronide and sulphate metabolites as well as the urinary clearance of unmetabolised paracetamol were estimated using non-linear, mixed-effects models. Results Mean (+/-SD) age and weight of the patients were 11.8+/-2.5 months and 9.1+/-1.9 kg. Clearances of paracetamol to paracetamol-glucuronide (%CV) and to paracetamol-sulphate were 6.6 (11.5) l/h and 7.5 (11.5) l/h respectively, standardised to a 70-kg person using allometric "1/4 power" models. Glucuronide formation clearance, but not sulphate formation, was related to age and increased with age from a predicted value in a neonate of 2.73 l/h/70 kg to a mature value of 6.6 l/h/70 kg with a maturation half-life of 8.09 months. Urine clearance of paracetamol-glucuronide, paracetamol-sulphate and unchanged paracetamol (%CV) were, respectively, 2.65, 3.03 and 0…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One study analysed the urinary excretion of the two conjugates (0-36 h) and found that the ratio of paracetamol-glucuronide to paracetamol-sulfate for neonates (1-2 days old), children (3-9 years) and older children (12 years old) was 0.34, 0.75 and 1.61, respectively, with an adult ratio of 1.80 (see figure 1).6”
From Paracetamol: pharmacology, prescribing and controversies (2016) · cites this paper as [6]
Citations
Cites
A General Model for the Origin of Allometric Scaling Laws in Biology
West, G. B., Brown, J. H., & Enquist, B. J. (1997) · Science · doi:10.1126/science.276.5309.122 · Cited by 5,016 · cited 1×
“75 for clearance and 1 for distribution volumes [12, 13, 14, 15, 16].”
BackgroundThe Fourth Dimension of Life: Fractal Geometry and Allometric Scaling of Organisms
West, G. B., Brown, J. H., & Enquist, B. J. (1999) · Science · doi:10.1126/science.284.5420.1677 · Cited by 1,718 · cited 1×
“75 for clearance and 1 for distribution volumes [12, 13, 14, 15, 16].”
BackgroundA Size Standard for Pharmacokinetics
Holford, N. H. G. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00001 · Cited by 482 · cited 1×
“The parameter values were standardised for a body weight of 70 kg using an allometric model [11].”
MethodSelf-citationGlucuronidation in Humans: Pharmacogenetic and Developmental Aspects
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 393 · cited 1×
“Enzyme activity is not only determined by postnatal age, but might also be regulated by both ontogenic and genetic processes, and these have not yet been elucidated [22].”
BackgroundContribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
MANYIKE, P., KHARASCH, E., KALHORN, T., & SLATTERY, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104736 · Cited by 355
Acetaminophen elimination kinetics in neonates, children, and adults
Miller, R. P., Roberts, R. J., & Fischer, L. J. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976193284 · Cited by 315
Anderson, B. J., van Lingen, R. A., Hansen, T. G., Lin, Y.-C., & Holford, N. H. G. (2002) · Anesthesiology · doi:10.1097/00000542-200206000-00012 · Cited by 240 · cited 2×
“8 l/h/70 kg at the age of 60 weeks post-conception [5].”
BackgroundSelf-citationSize, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients
Anderson, B. J., McKee, A. D., & Holford, N. H. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00001 · Cited by 210 · cited 1×
“The increase relative to adults may be an artefact of a non-biological based size model and has been observed when applied to clearance [21].”
BackgroundSelf-citationWest, J. R., Smith, H. W., & Chasis, H. (1948) · The Journal of Pediatrics · doi:10.1016/s0022-3476(48)80124-1 · Cited by 205 · cited 1×
“There was no effect of age on unchanged APAP clearance because glomerular filtration rate and renal blood flow, corrected for body size, are mature by 6 months of age [25].”
BackgroundAnderson, B. J., Woollard, G. A., & Holford, N. H. G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00231.x · Cited by 194 · cited 5×
“Final parameter estimates with covariate analyses are shown in Table 1 and Table 2. Pharmacokinetic estimates and maturational half-lives of VP/F and CLT/F were similar to those reported previously [ 10 ].”
MethodResultInfluentialSelf-citation
Cited by
The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics
Sachs, H. C., COMMITTEE ON DRUGS, Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Johnson, T., Neville, K., Paul, I. M., & Van den Anker, J. (2013) · Pediatrics · doi:10.1542/peds.2013-1985 · Cited by 555
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Anderson, B. J., & Holford, N. H. G. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.25 · Cited by 494
Self-citationLarson, A. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.006 · Cited by 451
Bartelink, I. H., Rademaker, C. M. A., Schobben, A. F. A. M., & van den Anker, J. N. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00003 · Cited by 418
“[16,43,64] These substrates are mainly glucuronipathways and renal excretion.”
BackgroundDevelopmental Pharmacokinetics in Pediatric Populations
Lu, H., & Rosenbaum, S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.4.262 · Cited by 358
Bouwmeester, N. J., Anderson, B. J., Tibboel, D., & Holford, N. H. G. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh042 · Cited by 294
Self-citationA Mechanistic Approach for the Scaling of Clearance in Children
Edginton, A. N., Schmitt, W., Voith, B., & Willmann, S. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645070-00004 · Cited by 217
Tips and traps analyzing pediatric PK data
Anderson, B. J., & Holford, N. H. G. (2011) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2011.03536.x · Cited by 163
Self-citationIntravenous Paracetamol (Acetaminophen)
Duggan, S. T., & Scott, L. J. (2009) · Drugs · doi:10.2165/00003495-200969010-00007 · Cited by 165
Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis1
Anderson, B. J., Pons, G., Autret‐Leca, E., Allegaert, K., & Boccard, E. (2005) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2005.01455.x · Cited by 157
Self-citationPrenatal and perinatal analgesic exposure and autism: an ecological link
Bauer, A. Z., & Kriebel, D. (2013) · Environmental Health · doi:10.1186/1476-069x-12-41 · Cited by 118
“0 [71,72].”
(EFSA), E. F. S. A. (2008) · EFSA Journal · doi:10.2903/j.efsa.2008.759 · Cited by 85
Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates
Allegaert, K., Anderson, B. J., Naulaers, G., Hoon, J. N. J. M. D., Verbesselt, R., Debeer, A., Devlieger, H., & Tibboel, D. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0756-x · Cited by 114
“Determination limit was 1 mg/l, and precision was 7% [4, 9].”
BackgroundSelf-citationCaparrotta, T. M., Antoine, D. J., & Dear, J. W. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2356-6 · Cited by 97
“Three of the studies did not detect the products of oxidative metabolism following therapeutic dosing in children [44, 46, 48]; adults have measurable products of oxidative metabolism following therapeutic dosing.”
BackgroundClinical Pharmacology of Paracetamol in Neonates: A Review
Pacifici, G. M., & Allegaert, K. (2014) · Current Therapeutic Research · doi:10.1016/j.curtheres.2014.12.001 · Cited by 106
Jahr, J. S., & Lee, V. K. (2010) · Anesthesiology Clinics · doi:10.1016/j.anclin.2010.08.006 · Cited by 105
“a decreased susceptibility to acetaminophen hepatotoxicity in infants and children.(41)”
BackgroundPrenatal exposure to acetaminophen and respiratory symptoms in the first year of life
Persky, V., Piorkowski, J., Hernández, E., Chávez, N., Wagner-Cassanova, C., Vergara, C., Pelzel, D., Enriquez, R., Gutierrez, S., & Busso, A. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60492-9 · Cited by 87
Allegaert, K., Vanhaesebrouck, S., Verbesselt, R., & van den Anker, J. N. (2009) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181a8cc0a · Cited by 68
“2).(6,26,25) A progressive increase in the contribution of APAP-G to overall paracetamol elimination during repeated rectal administration in neonates at birth was documented by Van Lingen et al.”
BackgroundAllegaert, K., Hoon, J. N. J. M. D., Verbesselt, R., Vanhole, C., Devlieger, H., & Tibboel, D. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb02088.x · Cited by 68
“in infants compared to the earlier work of Miller since they are the only ones who reported on metabolites of paracetamol during repeated administration (Table V) [8,17].”
BackgroundResultSelf-citationPain control: Non-steroidal anti-inflammatory agents
Jacqz-Aigrain, É., & Anderson, B. J. (2006) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2006.02.009 · Cited by 73
Self-citationAcetaminophen Pharmacokinetics in Children With Nonalcoholic Fatty Liver Disease
Barshop, N. J., Capparelli, E. V., Sirlin, C. B., Schwimmer, J. B., & Lavine, J. E. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181f9b3a0 · Cited by 67
Zuppa, A. F., Hammer, G. B., Barrett, J. S., Kenney, B. F., Kassir, N., Mouksassi, S., & Royal, M. A. (2011) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-16.4.246 · Cited by 63
“Hispanic or Latino 0 (0) 5 (20) 3 (12) 2 (9)”
Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling
Bouzom, F., & Walther, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00648.x · Cited by 55
Smits, A., Annaert, P., Cavallaro, G., De Cock, P. A. J. G., de Wildt, S. N., Kindblom, J. M., Lagler, F. B., Moreno, C., Pokorna, P., Schreuder, M. F., et al. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14958 · Cited by 55
Jaeschke, H., Murray, F. J., Monnot, A. D., Jacobson‐Kram, D., Cohen, S. M., Hardisty, J. F., Atillasoy, E. O., Hermanowski‐Vosatka, A., Kuffner, E. K., Wikoff, D. S., et al. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104859 · Cited by 58
Ontogeny of Hepatic Glucuronidation; Methods and Results
Krekels, E. H. J., Danhof, M., Tibboel, D., & Knibbe, C. A. J. (2012) · Current Drug Metabolism · doi:10.2174/138920012800840455 · Cited by 59
Self-citationCook, S. F., Stockmann, C. R., Samiee‐Zafarghandy, S., King, A. D., Deutsch, N., Williams, E. F., Wilkins, D. G., Sherwin, C. M. T., & van den Anker, J. N. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0408-1 · Cited by 56
“mol-sulfate increased with urine flow rate [33].”
MethodConfirmatory analysis for phase III population pharmacokinetics
Hu, C., Zhang, J., & Zhou, H. (2009) · Pharmaceutical Statistics · doi:10.1002/pst.403 · Cited by 54
Determinants of Drug Metabolism in Early Neonatal Life
Allegaert, K., van den Anker, J. N., Naulaers, G., & Hoon, J. N. J. M. D. (2007) · Current Clinical Pharmacology · doi:10.2174/157488407779422294 · Cited by 50
“Paracetamol is either sulfated or glucuronidated, and thus provides us with a drug substrate to simultaneously assess ontogeny of sulfation and glucuronidation in neonates and young infants [25,27].”
BackgroundPharmacogenomics of acetaminophen in pediatric populations: a moving target
Krasniak, A. E., Knipp, G. T., Svensson, C. K., & Liu, W. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00314 · Cited by 44
“Other investigators have demonstrated that glucuronide/sulfate ratios are 0.12 in premature neonates ( < 32 weeks), 0.28 in neonates 32–36 weeks post-conception, 0.34 in neonates 0–2 days old, 0.75 in children 3–9 years, and 1.8 in adults (Miller et al., 1976; van der Marel et al., 2003).”
BackgroundInfluentialParacetamol: a focus for the general pediatrician
Marzuillo, P., Guarino, S., & Barbi, E. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2239-5 · Cited by 48
“The sulfation pathway is mature at birth; however, the glucuronidation pathway takes about 2 years to mature [114].”
BackgroundAn Improved Approach for Confirmatory Phase III Population Pharmacokinetic Analysis
Hu, C., & Zhou, G. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008318670 · Cited by 41
Mooij, M. G., van Duijn, E., Knibbe, C. A. J., Windhorst, A. D., Hendrikse, N. H., Vaes, W. H. J., Spaans, E., Fabriek, B. O., Sandman, H., Grossouw, D., et al. (2014) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0176-8 · Cited by 33
“First, its metabolism shifts from primarily sulphation (AAP-sulphate [AAP-Sul]) to glucuronidation (AAP-glucuronide [AAP-Glu]) in the first year of life, as reflected by urinary metabolite kinetics [19, 20].”
BackgroundSelf-citationReith, D. M., Medlicott, N. J., Silva, K. D., Yang, L., Hickling, J., & Zacharias, M. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05029.x · Cited by 33
“In addition, the urinary clearance of APAP and its metabolites appears to be dependent on urine flow.(19) In addition, APAP-G under-”
BackgroundParacetamol and morphine for infant and neonatal pain; still a long way to go?
Baarslag, M. A., Allegaert, K., van den Anker, J. N., Knibbe, C. A. J., van Dijk, M., Simons, S. H. P., & Tibboel, D. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1254040 · Cited by 35
“One modeling study in 47 patients could not attribute any clearance to oxidative pathways [128] However, as renal clearance is lower in neo-”
BackgroundMethodSelf-citationBlecharz‐Klin, K., Joniec‐Maciejak, I., Jawna, K., Pyrzanowska, J., Piechal, A., Wawer, A., & Widy‐Tyszkiewicz, E. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.09.002 · Cited by 32
“Viberg et al. (2014) suggest that impaired spatial working memory and alteration in analgesic and anxiolytic response in mice after early life treatment to paracetamol are associated with changes in the level of neurotrophins involved in promotion of neuronal survival, axonal and dendritic…”
BackgroundPractical pain management in the neonate
de Lima, J., & Carmo, K. B. (2010) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2010.04.001 · Cited by 35
Pharmacokinetics of a Single Bolus of Propofol in Chinese Children of Different Ages
ShangGuan, W. N., Lian, Q., Aarons, L. J., Matthews, I., Wang, Z., Chen, X., Freemantle, N., & Smith, F. G. (2005) · Anesthesiology · doi:10.1097/00000542-200601000-00006 · Cited by 30
“Previous publications have shown the merit of including models for weight and age to explain changes in pharmacokinetics of several drugs in children.(7,8) Furthermore, publications regarding propofol also support this in both adults and children.”
BackgroundAnitta, S., & Sekar, C. (2023) · Results in Chemistry · doi:10.1016/j.rechem.2023.100816 · Cited by 29
Paracetamol: pharmacology, prescribing and controversies
Moriarty, C., & Carroll, W. (2016) · Archives of disease in childhood - Education & practice edition · doi:10.1136/archdischild-2014-307287 · Cited by 28
Knutsson, J., Tibbelin, A., & von Unge, M. (2006) · Acta Oto-Laryngologica · doi:10.1080/00016480600606715 · Cited by 26
“The use of preoperatively administered paracetamol might have affected the results concerning age difference since the analgesic medication could theoretically have different efficacy at different ages [13].”
BackgroundAllegaert, K., Vanhole, C., Vermeersch, S., Rayyan, M., Verbesselt, R., & de Hoon, J. (2007) · Early Human Development · doi:10.1016/j.earlhumdev.2007.08.005 · Cited by 25
“Although UGT-ontogeny is of pharmacokinetic and -dynamic relevance, data on ontogeny of UDP-glucuronosyltransferase (UGT) activity are scant and mainly based on studies using either morphine or paracetamol as drug probes [4–10].”
BackgroundPharmacokinetics of intravenous paracetamol in children and adolescents under major surgery
W�rthwein, G., Koling, S., Reich, A., Hempel, G., Schulze-Westhoff, P., Pinheiro, P. V., & Boos, J. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0873-6 · Cited by 25
“Based on literature data [8, 9] and visual examinations, potential pharmacokinetic models were the linear one- and two-compartment models.”
MethodRegulatory Review of Acetaminophen Clinical Pharmacology in Young Pediatric Patients
Ji, P., Wang, Y., Li, Z., Doddapaneni, S., Hertz, S., Furness, S., & Sahajwalla, C. G. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23331 · Cited by 24
Successful Use of [14C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism
Mooij, M. G., van Duijn, E., Knibbe, C. A. J., Allegaert, K., Windhorst, A. D., van Rosmalen, J., Hendrikse, N. H., Tibboel, D., Vaes, W. H. J., & de Wildt, S. N. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0508-6 · Cited by 23
“The AAP-glu/ AAP-sul ratio served as a surrogate marker for the relative contribution of glucuronidation and sulfation to AAP metabolism as in previous studies [18, 19, 21, 37].”
ResultSelf-citationPharmacokinetics and Pharmacology of Drugs Used in Children
Anderson, B. J., Lerman, J., & Coté, C. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-42974-0.00007-0 · Cited by 25
Self-citationRemoval of paracetamol from aqueous solution by containment composites
Hamoudi, S. A., Brahimi, M., Boucha, M., Hamdi, B., & Arrar, J. (2021) · Open Chemistry · doi:10.1515/chem-2020-0188 · Cited by 20
“The metabolization process occurred by a biochemical process that transformed the original molecules [2,4,5].”
BackgroundTraitement analgésique/antipyrétique: ibuprofène ou paracétamol? Mise au point
Olivé, G. (2006) · Therapies · doi:10.2515/therapie:2006034 · Cited by 17
Owens, K. H., Medlicott, N. J., Zacharias, M., Curran, N., Chary, S., Thompson-Fawcett, M. W., & Reith, D. M. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31826a70ea · Cited by 16
“Initial parameter estimates for paracetamol glucuronidation and sulfation were estimated from literature values.(13,14,20) The model used 7 differential equations, one for each of the series of data that described the parent drug and metabolites in plasma and urine.”
BackgroundMethodCORMACK, C. R. H., Sudan, S., ADDISON, R., Keating, J. W., Sherwood, R. A., & Ashley, E. (2006) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2005.01789.x · Cited by 15
Zeilmaker‐Roest, G. A., van Rosmalen, J., van Dijk, M., Koomen, E., Jansen, N. J. G., Kneyber, M. C. J., Maebe, S., den Berghe, G. V., Vlasselaers, D., Bogers, A. J. J. C., et al. (2018) · Trials · doi:10.1186/s13063-018-2705-5 · Cited by 13
“oxidation pathway forms NAPQI (N-acetyl-p-benzo-quinone imine) [20].”
InfluentialSelf-citationAguilar, F., Autrup, H. N., Barlow, S., Castle, L., Crebelli, R., Gontard, N., Gott, D. M., Grilli, S., Gürtler, R., Leclercq, C., et al. (2007) · Cited by 13
Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
Eissa, A., Tarau, E., Beuter, C., Radic, T., Watson, E., Sohns, M., Lefeber, C., & Hammer, G. B. (2021) · Journal of Pain Research · doi:10.2147/jpr.s269530 · Cited by 13
The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update On Selected Topics
Sachs, H. C. (2022) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610024433-appg · Cited by 13
Safety Issues of Pharmacological Acute Pain Treatment in Children
Rodieux, F., Piguet, V., Desmeules, J. A., & Samer, C. F. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1358 · Cited by 11
Kang, M. H., Villablanca, J. G., Bender, J. G., Matthay, K. K., Groshen, S. G., Sposto, R., Czarnecki, S., Ames, M. M., Reynolds, C. P., Marachelian, A., et al. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-256 · Cited by 10
Schweighardt, A. E., & Juba, K. M. (2018) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2019.1611692 · Cited by 8
A framework and case studies for evaluation of enzyme ontogeny in children’s health risk evaluation
Ginsberg, G., Vulimiri, S. V., Lin, Y.-S., Kancherla, J., Foos, B., & Sonawane, B. R. (2017) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2017.1369915 · Cited by 7
Fleishman, R. A., & Mayock, D. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00034-6 · Cited by 12
Chidambaran, V., & Sadhasivam, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-42974-0.00006-9 · Cited by 8
Haslund‐Krog, S. S., Hertel, S. A., Dalhoff, K., Poulsen, S. D., Christensen, U., Wilkins, D. G., van den Anker, J., Henriksen, T. B., & Holst, H. D. (2019) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2018-000427 · Cited by 5
Acetaminophen Therapy for Persistent Patent Ductus Arteriosus
Manalastas, M., Zaheer, F., Nicoski, P., Weiss, M., & Amin, S. (2021) · NeoReviews · doi:10.1542/neo.22-5-e320 · Cited by 5
Knutsson, J., Tibbelin, A., & von Unge, M. (2005) · Acta Oto-Laryngologica · doi:10.1080/00016480510043459 · Cited by 5
“This higher dose is not hepatotoxic when given as a single dose [24].”
BackgroundAllegaert, K., & Tibboel, D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096024 · Cited by 5
“Van der Marel et al. (2003) described acetaminophen disposition in 47 infants with a mean age of 11 months based on urine and blood samples collected following major craniofacial surgery.”
BackgroundSelf-citationClinical Pharmacology of Intravenous Paracetamol in Neonates
Allegaert, K., de Velde, M. V., & Naulaers, G. (2008) · The Open Anesthesiology Journal · doi:10.2174/1874321800802010050 · Cited by 4
“A maturational trend with a progressive increase in APAP-G elimination has been described in several single dose enteral paracetamol studies in neonates, infants and children, based on a progressive increase in activity of the glucuronidation pathway during childhood only reaching an adult G/S ratio at the age of 8 to…”
BackgroundParacetamol, widely used hardly understood
van der Marel, C. (2003) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 5
Wu, Y., Völler, S., Goulooze, S. C., Allegaert, K., Sherwin, C. M. T., van Rongen, A., Roofthooft, D. W. E., Simons, S. H. P., Tibboel, D., Flint, R. B., et al. (2025) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.70080 · Cited by 3
Self-citationEvaluation of the Potential Fetotoxic Effects of Tramadol in Female Pregnant Mice
Abdullah, B. A. (2018) · Zagazig Veterinary Journal/Zagazig Veterinary Journal (Online) · doi:10.21608/zvjz.2018.7617 · Cited by 3
“Tramadol has been reported to be absorbed more rapidly than morphine by about 95-100% from the small intestine and reached the highest peak after the 5 hours as highly distributed [4].”
BackgroundStudy Design and Simulation Approach
Läer, S., & Meibohm, B. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-20195-0_6 · Cited by 3
“There are numerous reports about developmental changes in metabolizing enzymes from birth to adolescence (van der Marel et al. 2003; Bouwmeester et al. 2004; see also Table 2).”
BackgroundNo urine, no urinary clearance
Anderson, B. J., & Holford, N. H. G. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0777-5 · Cited by 3
“Dear Sir, we recently estimated paracetamol metabolite clearance in infants [1] and have demonstrated a relationship between these clearances and urine production.”
BackgroundSelf-citationVoltammetric Assessment of Paracetamol on a CuONPs – MWCNTs Modified Glassy Carbon Electrode
Hegde, R., Poojary, V., & Kamath, K. (2024) · American Journal of Physical Chemistry · doi:10.11648/j.ajpc.20241303.11 · Cited by 2
Sharma, S., & Taft, D. R. (2025) · Life · doi:10.3390/life15071099 · Cited by 2
Influence of Maturation and Growth on Drug Metabolism from Fetal to Neonatal to Adult Life
Lindemalm, S., & van den Anker, J. N. (2014) · Pediatric and adolescent medicine · doi:10.1159/000364987 · Cited by 2
Best Practice for Fever Management With Intravenous Acetaminophen in Pediatric Oncology
Dokko, D. (2014) · Journal of Pediatric Oncology Nursing · doi:10.1177/1043454214543018 · Cited by 2
“Furthermore, young children may be more resistant to acetaminophen-induced hepatotoxicity than adults because they have larger glutathione stores and different metabolism means that result in less glucoronide and sulphate conjugates being excreted (van der Marel et al., 2003).”
BackgroundSmith, H. S., & Royal, M. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4836-7.00058-4 · Cited by 3
Paracetamol is both a friend and a foe: What should a pediatrician know? A clinical case
Zakharova, I. N., Berezhnaya, I. V., & Sugian, N. G. (2024) · Pediatrics Consilium Medicum · doi:10.26442/26586630.2024.3.202961 · Cited by 1
Drug Disposition in Neonates and Infants
Gyamfi, D., Amoafo, E. B., Kwapong, A. A., Fredua‐Agyeman, M., & Amponsah, S. K. (2025) · Wiley eBooks · doi:10.1002/9781394251315.ch7 · Cited by 1
Pharmacokinetics of a Single Bolus of Propofol in Chinese Children of Different Ages
(2007) · Survey of Anesthesiology · doi:10.1097/sa.0b013e31802f8c46 · Cited by 1
Accidental Paracetamol Poisoning: A Neonatal Case Report
Bokias, J. (2023) · Archives of Pediatrics · doi:10.29011/2575-825x.100273 · Cited by 1
Pharmacokinetics and Pharmacodynamics
Vicini, P. (2006) · Wiley eBooks · doi:10.1002/0471732877.emd202 · Cited by 1
Paracetamol rektal – das postoperative Analgetikum der Wahl?
Schlüter, E., & Reinhold, P. (2004) · Kinder- und Jugendmedizin · doi:10.1055/s-0037-1617829 · Cited by 1
“So konnte dann auch erst bei höheren Dosierungen (40-60 mg/kg KG) eine signifikante Schmerzreduktion nachgewiesen werden (7, 49, 51).”
BackgroundPendo, O. Q. (2021) · Cited by 1
Is Acetaminophen More Prone To Biliary Excretion Given Orally Than Rectally In Infants?
Srinivas, N. R. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.03.006
“Acetaminophen disposition and clearance in infants is governed by efficient Phase 2 conjugation pathways via glucuronidation and sulfation.(2) Almost equal contribution is made by these two pathways for the clearance of cetaminophen (glucuronide clearance: 6.”
BackgroundLü, H. (2013) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-lu-hong-2013
“The four members of the human CYP2C family: CYP2C8, 2C18, 2C9 and 2C19, account for 18% of the total cytochrome P450 in the adult liver [25] and metabolize about 29% of clinically used drugs [10].”
BackgroundADVANCED POPULATION PHARMACOKINETIC MODELLING TO QUANTIFY SELECTED CHARACTERISTICS OF DRUGS
Bonn, R. F.-W.-U., Mohammed, K. S., & Abduljalil, A. (2010)
Läer, S. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31822233c1
“Numerous studies have detailed the developmental changes associated with drug metabolizing enzymes from birth to adolescence.(37,38) For example, almost every known CYP450 isoform has a distinct pattern of maturation, which might influence drug clearance in specific age groups.”
BackgroundCheung, M. M. L. (2009) · NVA (Nasjonalt vitenarkiv) · Cited by 1
Bruk av paracetamol i den postoperative smertebehandlingen av nyfødte
Oslo, U. I. (2009)
Neonatology for Anesthesiologists
Gregory, G. A., & Brett, C. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34125-7.00023-1 · Cited by 2
Supplementary material A: Commentaries
Ainsworth, S. B. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198840787.005.0001
Krishna, N. M., & Ganga, S. (2021) · International Journal of Advanced Research in Medicine · doi:10.22271/27069567.2021.v3.i2i.404
Hegde, R. N., Poojary, V., & Nandibewoor, S. T. (2024) · Brazilian Journal of Analytical Chemistry · doi:10.30744/brjac.2179-3425.ar-17-2024
Hegde, R. N., Vishwanatha, P., & Nandibewoor, S. T. (2024) · Russian Journal of Physical Chemistry A · doi:10.1134/s0036024424700298
Ikeh, G. O., Nwafor, M. N., Ndubuisi, M. N., & Okolo, K. O. (2024) · Journal of Complementary and Alternative Medical Research · doi:10.9734/jocamr/2024/v25i12603
van Rongen, A., Grijseels, R., Calvier, E. A. M., Allegaert, K., Knibbe, C. A. J., & Krekels, E. H. J. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03948-7
Paracetamol-induced hepatotoxicity in children less than five years old in Monrovia, Liberia
Haidar, M. (2019) · theses.fr (ABES) · doi:10.70675/77d6801ezf0c3z4947zb107z6d2a82f3c930
Clinical pharmacology of oral paracetamol in a paediatric population with fever
Salis, G. (2025) · Otago University Research Archive (University of Otago)
Metadata
- Authors
- van der Marel, C. D., Anderson, B. J., van Lingen, R. A., Holford, N. H. G., Pluim, M. A. L., Jansman, F. G. A., van den Anker, J. N., & Tibboel, D.
- Affiliations
- Maastricht University Medical Centre (NL)
- University of Auckland (NZ)
- Erasmus MC (NL)
- Isala (NL)
- Corresponding author
- Tibboel, Dick
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2003-05-22
- Volume
- 59
- Issue
- 3
- Pages
- 243-251
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W1999869154
- Cited by
- 98
- References
- 41
- Citations by year
- 2025: 4 · 2024: 5 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 2 · 2019: 5 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 8 · 2013: 5 · 2012: 3
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Keywords
- paracetamol, pharmacokinetics, infants, paracetamol glucuronide, glucuronidation, sulfation, urinary clearance, postoperative analgesia, craniofacial surgery, allometric scaling, age-related clearance, neonates, children, suppository formulation
- MeSH terms
- Acetaminophen, Female, Humans, Infant, Male, Metabolic Clearance Rate, Pain, Postoperative, Postoperative Pain, Analgesics, Non-Narcotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.